To evaluate the effectiveness of photobiomodulation therapy (PBMT) in the prevention of trismus in patients undergoing Intensity-Modulated Radiotherapy (IMRT) and Volumetric Modulated Arc Therapy (VMAT), through a randomized, triple-blind, placebo-controlled clinical trial. A total of 46 patients undergoing radiotherapy (RT) for head and neck cancer (HNC) were included. Patients were equally and randomly allocated to PBMT and PBMT placebo groups and were evaluated daily by measuring mouth opening, pain during mouth opening, and pain on palpation of the masticatory muscles using the Visual Analog Scale (VAS). An extraoral infrared laser (~ 808 nm), power of 0.1 W, energy of 3 J, 30 s (107 J/cm²) per point was used, applied extraorally to the anterior temporalis (AT), masseter (MM), and temporomandibular joints (TMJ), and intraorally to the medial pterygoid muscle (MP). The Food Quality Inventory (ASGP) and quality of life analysis (QoL) (OHIP-14) were also applied. Statistical analysis included Student’s t-test, Mann-Whitney test, and linear regression models (p 0.05). Mouth opening did not differ between the groups at the six-month follow-up. Photobiomodulation therapy was effective in preventing trismus and masticatory muscle pain during radiotherapy. Clinical Trial Registration Clinical trial number: RBR-67qxnt9 (registered on 16/04/2025).
Franco et al. (Sat,) studied this question.